FDA faults company behind recalled eye drops for multiple violations
Global Pharma's eye drops have been linked to a U.S. outbreak which has led to at least five people losing their vision.
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19. Previously, he was a campaign reporter for CBS News based out of Las Vegas, where he was raised. He covered presidential, Senate and House candidates for the 2020 election cycle in Arizona, California, Nevada and New Mexico. He has also worked in Washington for "Face the Nation" and in New York for the "CBS Evening News." Tin graduated from Columbia University in 2017 with a bachelor's degree in political science.
Global Pharma's eye drops have been linked to a U.S. outbreak which has led to at least five people losing their vision.
Dr. Ashish Jha said he was hopeful insurers would still cover COVID-19 tests after the official end of the public health emergency.
Unvaccinated Americans would be able to effectively skip to the updated "bivalent" booster doses.
Direct and indirect effects of the COVID-19 pandemic likely contributed to the larger increase in cardiovascular deaths in 2020.
Massachusetts has identified two cases so far that were infected by the strain, which appears to have developed some resistance to ceftriaxone.
Massachusetts has identified two cases so far that were infected by the strain, which appears to have developed some resistance to ceftriaxone.
The decline was not accompanied by a rise in exemptions, the CDC says, suggesting many children could still catch up on their shots.
Pivotal results on a variety of next generation approaches are expected soon, as a panel of FDA advisers is set to weigh the future of immunization against SARS-CoV-2.
XBB.1.5's prevalence remains highest in the Northeast, according to the CDC's latest estimates.
The CDC cited concerns over the COVID-19 surge in China and "the lack of adequate and transparent" data from the country's health authorities.
The CDC cited concerns over the COVID-19 surge in China and "the lack of adequate and transparent" data from the country's health authorities.
A statement released by U.S. officials cited "mounting concerns" over the COVID-19 surge in China and "the lack of transparent data" from the country.
The CDC cited concerns over the COVID-19 surge in China and "the lack of adequate and transparent" data from the country's health authorities.
The Biden administration reopened requests for four free tests per household through the U.S. Postal Service portal a week ago.
The CDC released final data showing that the American life expectancy rate has fallen back to what it was in 1996.